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Background:  We  have  reported  that   and   adrenergic  blockers  could  protect  against  emotional
stress-induced  cardiac  dysfunction  but  those  protective  effects  of   adrenergic  blockers  with  intrinsic
sympathomimetic  activity  (ISA),  such  as celiprolol,  are  unknown.  The  purpose  of  this  study  is to  evaluate
whether  ISA  could  relate  with  this  protective  effect.
Methods  and results:  Rats  medicated  with  celiprolol  (8 mg/kg),  metoprolol  (4  mg/kg),  or vehicle,  were
restrained  for  30 min  (immobilization  stress:  IMO)  to  reproduce  emotional  stress,  and  anesthetized  to
release stress.  We  measured  the  fractional  area  change  (FAC)  using  an  echocardiography  (SONOS5500)
with s12  probe  (frequency:  5–12  MHz,  frame  rate: 120 Hz)  at the end  of IMO  and  every  10  min  for  1  h.
During  IMO,  FAC  in rats  with  a premedication  of metoprolol  was  lower  than  in  those  with  a  premedication
of  vehicle  or  celiprolol.  At  20  min  after  IMO,  FAC  in rats  with  a  premedication  of  celiprolol  was signiﬁcantlyntrinsic sympathomimetic activity higher  than  that with  a premedication  of metoprolol  or vehicle  (84  ±  9%  vs.  65  ±  3% or 60  ±  7%,  p  <  0.05).
At  60  min  after  IMO,  FAC in  rats  with a premedication  of  vehicle  or  celiprolol  recovered,  but FAC  in  rats
with  a premedication  of  metoprolol  did not.
Conclusion:  Acute  premedication  with  celiprolol  could  prevent  a sudden  drop  of  cardiac  function  after
acute stress  such  as IMO.  ISA  might  have  an  important  role in  preventing  stress-induced  cardiac  dysfunc-
tion.
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A unique acute cardiac attack called “takotsubo cardiomy-
pathy” or “transient left ventricular apical ballooning,” occurs
redominantly in postmenopausal women in association with
motional or physical stress [1–3]. The incidence of takotsubo car-
iomyopathy was also reported to increase just after the onset of
 major earthquake [4].  Emotional stress could induce myocardial
schemia by activation of the sympathetic nervous system [5,6].
oradrenaline and adrenaline could act directly on the heart via
peciﬁc cardiac adrenoceptors, increasing heart rate and myocar-
ial oxygen demand. The sympathetic nervous system could have
mpacts on the heart by increasing systemic blood pressure and
ontraction of vascular smooth muscle cells. Funahashi et al.
eported that altered expression of several miRNAs was related
o the reduced catecholamine sensitivity in mildly symptomatic
atients with idiopathic dilated cardiomyopathy [7].
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Immobilization stress (IMO) in a rat provides a well-
known animal model of emotional stress, which activates the
hypothalamic–pituitary–adrenocortical system and the sympa-
thoadrenal system [8].  We have succeeded in developing a model
of this clinical condition in rats [9–12].  Recently, we reported the
preventive mechanism of  and  adrenergic blockers, such as
labetalol, or a calcium channel blocker, such as azelnidipine, on
emotional stress-induced cardiovascular response in rats [13–15].
However, only administration of  adrenergic blockers could not
prevent stress-induced cardiac dysfunction. The purpose of this
study is to evaluate whether intrinsic sympathomimetic activity
(ISA) could relate with this protective effect.
Materials and methods
Materials
Thirty-three male Spraque-Dawley rats (8–11 weeks’ old) were
purchased from Japan SLC Inc. (Shizuoka, Japan) and housed in
a temperature-controlled environment. Experiments were per-
formed after allowing free access to food and water for 2 weeks.
Rats were restrained for 30 min  to reproduce emotional stress
by securing them on their back to a board using adhesive tape (IMO)
vier Ltd. All rights reserved.
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Fig. 1. Study protocol. Rats were restrained for 30 min  to reproduce emotional stress
by  securing them on their back to a board using adhesive tape. Rats were medicated
with celiprolol (8 mg/kg) or vehicle 180 min  before IMO  and metoprolol (4 mg/kg)
90 min before IMO. Immediately after IMO, rats were anesthetized with sodium
pentobarbital and echocardiographic parameters, blood pressure, and heart rate
were measured at the end of IMO  and every 10 min  under anesthesia for 1 h. On
the  following day of IMO, echocardiographic parameters were also measured under
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aline levels [8].  Increased catecholamines can augment the
ventricular contraction while abrupt cessation of positive inotropic
and clonotropic drive may  reduce the contractility. On the contrary,nesthesia with sodium pentobarbital (40 mg/kg, ip) without prior IMO  to examine
he  effects of anesthetization. IMO, immobilization stress; BP, blood pressure; HR,
eart rate.
n the same manner as previously reported [9–15]. Rats were med-
cated with celiprolol (8 mg/kg) or vehicle 180 min  before IMO  and
etoprolol (4 mg/kg) 90 min  before IMO. Immediately after IMO
or 30 min, rats were anesthetized with sodium pentobarbital and
chocardiographic parameters, blood pressure, and heart rate were
easured at the end of IMO  and every 10 min  under anesthesia for
 h. On the following day of IMO, echocardiographic parameters
ere also measured under anesthesia with sodium pentobarbital
40 mg/kg, ip) without prior IMO  to examine the effects of anes-
hesia (Fig. 1). This study was approved by the Osaka University
edical school animal care and use committee and were in com-
liance with the Osaka University medical school guidelines for the
are and use of laboratory animals.
stimation of cardiac function by echocardiography
Immediately after IMO, 17 rats (vehicle group, 6; metoprolol
roup, 5; celiprolol group, 6) were anesthetized with sodium pen-
obarbital (40 mg/kg, ip). End diastolic area (EDA) and end systolic
rea (ESA) were measured at the papillary muscle levels using
ONOS5500 (Philips Medical Systems, Andover, MA,  USA) with s12
robe (frequency: 5–12 MHz, frame rate: >120 Hz) and fractional
eft ventricular area change (FAC) was calculated by the formula:
EDA − ESA) × 100/EDA in the same manner as previously reported
15].
emodynamic measurement
During IMO, we also measured systemic blood pressure from
 femoral artery and heart rate from electrocardiogram in 16
ats (vehicle group, 6; metoprolol group, 5; celiprolol group,
) under local anesthesia. Immediately after IMO, all rats were
nesthetized with sodium pentobarbital (40 mg/kg, ip) and we
easured systemic blood pressure and heart rate at every 10 min
nder anesthesia for 60 min.tatistical analysis
Data are shown as mean ± SD. Statistical analysis was performed
y two-way ANOVA followed by Fisher’s protected least signiﬁcantiology 60 (2012) 470–474 471
difference test, or Student’s t-test using JMP  software (SAS Campus,
Cary, NC, USA). Differences were considered signiﬁcant at p < 0.05.
Results
Left ventricular contraction
Left ventricle showed hypercontraction in the vehicle and
celiprolol groups during IMO  stress (95 ± 2% and 92 ± 6%, respec-
tively). There was no signiﬁcant difference in FAC during IMO  in
both groups. FAC during IMO  stress in the metoprolol group was
signiﬁcantly lower than FAC in other two  groups (86 ± 3%, p < 0.05).
Just after induction of anesthesia, left ventricular contraction
was signiﬁcantly reduced in the vehicle and metoprolol groups.
Reduction in FAC was most prominent at 20 min  after the induc-
tion of anesthesia and FAC at 20 min  in the vehicle and metoprolol
groups was  signiﬁcantly lower than FAC in the celiprolol group
(60 ± 7%, 65 ± 3% vs. 84 ± 9%, p < 0.05). At 60 min after the induction
of anesthesia, FAC in the vehicle and celiprolol groups recovered
(94 ± 3% and 94 ± 2%). However, FAC at 60 min  in the metoprolol
group did not (75 ± 4%).
In contrast, FAC without prior stress was not signiﬁcantly
impaired in the vehicle and celiprolol groups, however, FAC with-
out prior stress in the metoprolol group was lower than FAC in the
vehicle and celiprolol groups (Fig. 2).
Blood pressure and heart rate
Mean blood pressure in the metoprolol group during IMO stress
was signiﬁcant lower than that in the vehicle group (116 ± 9 mmHg
vs. 126 ± 9 mmHg, p < 0.05). Mean blood pressure in the celiprolol
group during IMO  stress was  also lower than that in the vehicle
group (113 ± 4 mmHg  vs. 126 ± 9 mmHg) but not statistically sig-
niﬁcantly. Just after induction of anesthesia, mean blood pressure
in the three groups was  signiﬁcantly reduced. Mean blood pressure
in the metoprolol group tended to be lower than that in the other
two groups.
Heart rate during IMO  stress in the metoprolol group during
IMO  stress tended to be lower than that in the vehicle group
(467 ± 55 bpm vs. 514 ± 9 bpm). Also heart rate during IMO stress
in the celiprolol group during IMO  stress was lower than that in the
vehicle group (501 ± 18 bpm vs. 514 ± 9 bpm) but not statistically
signiﬁcantly. Just after induction of anesthesia, heart rate in the
three groups was  signiﬁcantly reduced, but heart rate in the celipro-
lol group was higher than that in the other two groups and heart
rate in the vehicle group was  higher than that in the metoprolol
group (Fig. 3).
Discussion
The present study demonstrated that the  adrenergic blocker
with ISA, celiprolol, attenuated IMO-induced left ventricular sys-
tolic dysfunction.
Mechanism of IMO-induced LV dysfunction
IMO  signiﬁcantly increased plasma adrenaline and noradren-high levels of catecholamine can damage cardiac tissue and dimin-
ish left ventricular function because of Ca2+ overload, free radical
formation, myocardial ischemia, increase of ventricular afterload,
and heart rate [16,17].
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Fig. 2. Time course of FAC. Time course of FAC after the end of IMO  and induction to anesthesia (left panel) and anesthesia without IMO  (right panel) in the three groups.
Left  ventricle showed hyper contraction in the vehicle and celiprolol groups during IMO  stress (95 ± 2% and 92 ± 2%, respectively). FAC during IMO stress in the metoprolol
group  was signiﬁcantly lower than FAC in the other two groups (86 ± 3%, p < 0.05). Just after induction of anesthesia, left ventricular contraction was signiﬁcantly reduced in
the  vehicle and metoprolol groups. Reduction in FAC was most prominent at 20 min  after the induction of anesthesia and FAC at 20 min  in the vehicle and metoprolol groups
was  signiﬁcantly lower than FAC in a celiprolol group (60 ± 7%, 65 ± 3% vs. 84 ± 9%, p < 0.05). At 60 min  after the induction of anesthesia, FAC in the vehicle and celiprolol
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ehicle  and celiprolol groups, however, FAC without prior stress in the metoprolol g
hows the mean ± SD. FAC, fractional area change; IMO, immobilization stress.
ffects of ˇ-blocker without ISA
Metoprolol could attenuate increases in systemic blood pressure
nd heart rate during IMO, however metoprolol could not prevent
MO-induced left ventricular systolic dysfunction. Pathophysiolog-
cal mechanisms of takotsubo cardiomyopathy are still unknown.
owever, potential pathophysiological mechanisms include
atecholamine-induced myocardial stunning or hyperkinesis of
ig. 3. Time course of mean blood pressure and heart rate after the end of IMO  and induc
as  signiﬁcantly lower than that in the vehicle or celiprolol groups (113 ± 4 mmHg  vs. 126
ressure in the three groups was signiﬁcantly reduced. Mean blood pressure in the metop
MO  stress in the metoprolol group during IMO  stress tended to be lower than that in the o
f  anesthesia, heart rate in the three groups was signiﬁcantly reduced, but heart rate in t
he  vehicle group was  higher than that in the metoprolol group. Each point and vertical b did not. In contrast, FAC without prior stress was  not signiﬁcantly impaired in the
was lower than FAC in the vehicle and celiprolol groups. Each point and vertical bar
the basal left ventricular segments, coronary vasospasm, plaque
rupture, myocarditis, and genetic factors. So -blockers are sup-
posed to be effective to prevent catecholamine-induced myocardial
stunning [18]. We  already reported that pretreatment with meto-
prolol suppressed the stress-induced tachycardia but not the
elevation of the ST segment at the II, III, and aVF leads. In contrast,
pretreatment with a combination of prazosin and metoprolol com-
pletely abolished the stress-induced tachycardia and the elevation
tion to anesthesia. Mean blood pressure in the metoprolol group during IMO stress
 ± 9 mmHg, 116 ± 9 mmHg, p < 0.05). Just after induction of anesthesia, mean blood
rolol group tended to be lower than that in the other two groups. Heart rate during
ther two groups (467 ± 55 bpm vs. 514 ± 9 bpm, 501 ± 18 bpm). Just after induction
he celiprolol group was  higher than that in the other two groups and heart rate in
ar shows the mean ± SD. IMO, immobilization stress.
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[6]  Rozanski A, Bairey CN, Krantz DS, Friedman J, Resser KJ, Morell M,  Hilton-
Chalfen S, Hestrin L, Bietendorf J, Berman DS. Mental stress and the induction
of  silent myocardial ischemia in patients with coronary artery disease. N EnglF. Ishikura et al. / Journal o
f the ST segment [10]. These results indicate that inhibition of both
1- and 1-adrenoceptors is necessary for the inhibition of stress-
nduced electrocardiographic changes. We  have demonstrated that
he expression of immediate early genes (IEG) in response to IMO
tress was mediated via activation of - or -adrenoceptors [9].
nly simultaneous blockade of - and -adrenoceptors completely
bolished expression of IEG in the rat heart, but expression was
ot abolished by an -adrenoceptor blocker or a -adrenoceptor
locker.
ffects of ˇ-blocker with ISA
Celiprolol, a unique -blocking agent, has been reported to have
asodilatory capacity which may  be due to partial 2-receptor ago-
istic activity [19,20].  Heusser et al. reported that celiprolol did
ot alter resting levels of hemodynamics, forearm blood ﬂow, and
ympathetic nerve activity to muscle nor did it alter responses to
ower body negative pressure or the cold pressor test. In contrast,
etoprolol produced signiﬁcant decreases in forearm blood ﬂow
nd heart rate, and increases in forearm vascular resistance and
lood pressure. And they concluded that the lack of peripheral vaso-
onstriction seen after acute administration of celiprolol is most
ikely due to its partial 2-receptor agonistic effect [21]. Kobayashi
t al. reported that celiprolol administration resulted in a signiﬁ-
ant improvement in cardiovascular remodeling and suppression
f transforming growth factor-1 gene expression. And they con-
luded that celiprolol suppresses VCAM-1 expression because of
nhibition of oxidative stress, nuclear factor-kappa B, and signal
ransduction, while increasing eNOS via stimulation of the PI3K-
kt signaling pathway and improving cardiovascular remodeling
22]. So, cardiac and peripheral effects of celiprolol might share
ommon traits with  and -blockade, but intimate mechanisms
re still unknown.
ffect of anesthesia
On the ﬁrst day, rats were anesthetized with sodium pentobar-
ital (40 mg/kg, ip) immediately after IMO  to exclude central nerve
ctions. Anesthetization with sodium pentobarbital itself might
educe cardiac function. So we also measured FAC under anesthe-
ia with sodium pentobarbital without prior IMO  to examine the
ffects of anesthesia on the following day of IMO. FAC without prior
tress was not signiﬁcantly impaired in the vehicle and celipro-
ol groups, so anesthetization with sodium pentobarbital did not
ave a strong effect in either group. However, FAC in the metopro-
ol group without prior stress was lower than FAC in the vehicle
nd celiprolol groups. The negative inotropic activity of metoprolol
ight be augmented under anesthetization.
tudy limitations
In this study, we did not study responses at molecular level. We
ave already investigated and reported cardiac and vascular gene
roﬁles in response to IMO  in rats. In response to IMO, expression
f 46 genes was signiﬁcantly altered in the heart and that of 49
enes was signiﬁcantly altered in the aorta [14]. However, patho-
hysiological mechanisms for takotsubo cardiomyopathy are still
nknown.
In the human heart, 1-adrenoceptors are reported to be pre-
ominant and the density of 1-adrenoceptors is very low [23],
hile in the rat heart the densities of 1- and 1-adrenoceptors
re almost equal [24,25]. So we could not show the effectiveness of
eliprolol to prevent emotional stress-induced cardiac dysfunction
n humans. Some clinical reports suggested that celiprolol could be
ore effective on diastolic function or exercise capacity compared
o metoprolol [26,27]. And celiprolol is also reported to have effectsiology 60 (2012) 470–474 473
on cardiovascular reactivity to laboratory stressors in patients with
hypertension [28].
We could not examine the dose response to IMO-induced
left ventricular systolic dysfunction. In this study, we examined
8 mg/kg of celiprolol and 4 mg/kg of metoprolol, which will be
the maximum clinical dose for a patient whose body weight is
50 kg. Eight mg/kg of celiprolol slightly decreased blood pressure
and heart rate during IMO, but not statistically signiﬁcantly. Eight
mg/kg of celiprolol is not enough to decrease blood pressure and
heart rate, but has enough effect to prevent IMO-induced left ven-
tricular systolic dysfunction and 4 mg/kg of metoprolol signiﬁcant
decreased heart rate. So 8 mg/kg of celiprolol and 4 mg/kg of meto-
prolol could be suitable doses.
In this study, we could not evaluate electrocardiography, how-
ever, the echocardiographic examination could be a more sensitive
method to detect cardiac dysfunction than the elevation of the ST
segment.
Clinical implications
The pathogenesis of takotsubo cardiomyopathy has not yet
been determined, while clinical observations strongly suggest that
the trigger of attack is emotional or physical stress and it pre-
dominantly occurs in post-menopausal women. In this study, we
conﬁrmed using animal models that in emotional stress-induced
left ventricular dysfunction, celiprolol administration partially
improved the contractility. Many -blocking agents could be use-
ful for prevention of stress-induced heart attacks. -Blocking
agents without ISA which reduce heart rate during the day- and
night-time, are difﬁcult to prescribe for elderly patients. Celipro-
lol, -blocking agents with ISA did not reduce heart rate at
night-time in elderly patients [29]. So -blocking agents with ISA
might be useful to prevent stress-induced heart attacks in elderly
patients.
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